Investor mix
6 investors on record; lead investors include Index Ventures, Sofinnova Partners, Edmond de Rothschild; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 67% |
| Private equity | 1 | 17% |
| Bank & private debt | 1 | 17% |
Developer of bioconjugate vaccines to treat a range of bacterial infections
6 investors on record; lead investors include Index Ventures, Sofinnova Partners, Edmond de Rothschild; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 67% |
| Private equity | 1 | 17% |
| Bank & private debt | 1 | 17% |